Evidence map›Paper›PMID 29287769›Full record

ReviewSeminars in arthritis and rheumatism2018

Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Jean-Yves L Reginster, Nigel K Arden, Ida K Haugen, Francois Rannou, Etienne Cavalier, Olivier Bruyère, Jaime Branco, Roland Chapurlat, Sabine Collaud Basset, Nasser M Al-Daghri and 12 more

Open access · hybridAbstract readConsensus StatementReview
In one paragraph

Review in Seminars in arthritis and rheumatism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. The woman's hand.Revista da Associacao Medica Brasileira (1992) · 2023
    Article
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Systematic Pharmacological Methodology to Explore the Pharmacological Mechanism of Siwu Decoction for Osteoporosis.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 17 institutions in 12 countries.

Jean-Yves L ReginsterDepartment of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
Nigel K ArdenArthritis Research UK Centre for Sport, Exercise and Osteoarthritis, University of Oxford, Oxford, UK; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
Ida K HaugenDepartment of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
Francois RannouDivision of Physical Medicine and Rehabilitation, AP-HP Cochin Hospital, Université Paris Descartes Sorbonne Paris Cité, Paris, France.
Etienne CavalierDepartment of Clinical Chemistry, University of Liège, CHU Sart-Tilman, Route 52, Porte 53, Domaine du Sart-Tilman, Liège, Belgium.
Olivier BruyèreDepartment of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
Jaime BrancoDepartment of Rheumatology, CEDOC, NOVA Medical School, Universidade Nova de Lisboa, CHLO, Hospital Egas Moniz, Lisbon, Portugal.
Roland ChapurlatDivision of Rheumatology, INSERM UMR 1033, Université de Lyon, Hôpital E Herriot, Lyon, France.
Sabine Collaud BassetTRB Chemedica International SA, Geneva, Switzerland.
Nasser M Al-DaghriBiochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia.
Elaine M DennisonMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
Gabriel Herrero-BeaumontDepartment of Rheumatology, Bone and Joint Research Unit, Fundación Jiménez Diaz, Universidad Autonoma, Madrid, Spain.
Andrea LaslopScientific Office, Austrian Medicines and Medical Devices Agency, AGES, Vienna, Austria.
Burkhard F LeebSecond Department of Medicine, Centre for Rheumatology Lower Austria, State Hospital Stockerau, Stockerau, Austria.
Stefania MaggiAging Program, National Research Council, Padova, Italy.
Ouafa MkinsiRheumatology Department, IBN ROCHD University Hospital, Casablanca, Morocco.
Anton S PovzunScientific Research Institute of Emergency Care n.a. l.l. Dzhanelidze, Saint-Petersburg, Russia.
Daniel Prieto-AlhambraMusculoskeletal Pharmaco and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK; NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK.
Thierry ThomasDepartment of Rheumatology, Hôpital Nord, CHU de St-Etienne & INSERM 1059, Université de Lyon, Saint-Etienne, France.
Daniel UebelhartDivision of Musculoskeletal, Internal Medicine and Oncological Rehabilitation, Department of Orthopaedics and Traumatology, Hôpital du Valais (HVS), Centre Hospitalier du Valais Romand (CHVR), CVP, Crans-Montana, Switzerland.
Nicola VeroneseAging Program, National Research Council, Padova, Italy.
Cyrus CooperMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK; NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK. Electronic address: cc@mrc.soton.ac.uk.
University of Liège · BENational Research Council · ITUniversité Claude Bernard Lyon 1 · FRAustrian Agency for Health and Food Safety · ATCentre Hospitalier Universitaire Ibn Rochd · MADiakonhjemmet Hospital · NOHôpital du Valais · CHHospital Universitario Fundación Jiménez Díaz · ESKing Saud University · SAMRC Lifecourse Epidemiology Unit · GBNIHR Oxford Musculoskeletal Biomedical Research Centre · GBResearch Institute of Emergency Care · RUSorbonne Paris Cité · FRTRB Chemedica International (Switzerland) · CHUniversidade Nova de Lisboa · PTUniversity of Oxford · GBUniversity of Southampton · GB

Funding

Medical Research Council G0400491Medical Research Council MC_U147574212Medical Research Council MC_U147574234Medical Research Council MC_U147574237Medical Research Council MC_U147585819Medical Research Council MC_U147585824Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UU_12011/1Versus Arthritis 19583
6 · The paper itself

Abstract

objectivesTo gather expert opinion on the conduct of clinical trials that will facilitate regulatory review and approval of appropriate efficacious pharmacological treatments for hand osteoarthritis (OA), an area of high unmet clinical need.

methodsThe European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal diseases (ESCEO) organized a working group under the auspices of the International Osteoporosis Foundation (IOF) and the World Health Organization (WHO).

resultsThis consensus guideline is intended to provide a reference tool for practice, and should allow for better standardization of the conduct of clinical trials in hand OA. Hand OA is a heterogeneous disease affecting different, and often multiple, joints of the thumb and fingers. It was recognized that the various phenotypes and limitations of diagnostic criteria may make the results of hand OA trials difficult to interpret. Nonetheless, practical recommendations for the conduct of clinical trials of both symptom and structure modifying drugs are outlined in this consensus statement, including guidance on study design, execution, and analysis.

conclusionsWhile the working group acknowledges that the methodology for performing clinical trials in hand OA will evolve as knowledge of the disease increases, it is hoped that this guidance will support the development of new pharmacological treatments targeting hand OA.

Indexed as

Antirheumatic AgentsClinical Trials as TopicOsteoarthritisResearch DesignConsensusGuidelines as TopicHand JointsHumansAntirheumatic AgentsClinical trialsGuidelinesHand osteoarthritisPharmacological treatment

Identifiers

PMID29287769
PMCPMC5907911
OpenAlexW2773573797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.